AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $918,000 | +1.7% | 43,836 | +16.2% | 0.05% | -20.7% |
| Q4 2018 | $903,000 | +284.3% | 37,734 | +337.0% | 0.06% | +427.3% |
| Q3 2018 | $235,000 | -68.6% | 8,634 | -69.0% | 0.01% | -63.3% |
| Q2 2018 | $748,000 | +264.9% | 27,834 | +411.7% | 0.03% | +233.3% |
| Q4 2017 | $205,000 | – | 5,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|